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Objective: Roseburia hominis is a flagellated gut anaerobic bacterium belonging to 
the Lachnospiraceae family within the Firmicutes phylum. A significant decrease of 
R. hominis colonization in the gut of ulcerative colitis patients has recently been demon-
strated. In this work, we have investigated the mechanisms of R. hominis–host cross talk 
using both murine and in vitro models.
Design: The complete genome sequence of R. hominis A2-183 was determined. C3H/
HeN germ-free mice were mono-colonized with R. hominis, and the host–microbe inter-
action was studied using histology, transcriptome analyses and FACS. Further investi-
gations were performed in vitro and using the TLR5KO and DSS-colitis murine models.
results: In the bacterium, R. hominis, host gut colonization upregulated genes involved in 
conjugation/mobilization, metabolism, motility, and chemotaxis. In the host cells, bacterial 
colonization upregulated genes related to antimicrobial peptides, gut barrier function, 
toll-like receptors (TLR) signaling, and T cell biology. CD4+CD25+FoxP3+ T cell numbers 
increased in the lamina propria of both mono-associated and conventional mice treated 
with R. hominis. Treatment with the R. hominis bacterium provided protection against DSS-
induced colitis. The role of flagellin in host–bacterium interaction was also investigated.
conclusion: Mono-association of mice with R. hominis bacteria results in specific 
bidirectional gene expression patterns. A set of genes thought to be important for host 
colonization are induced in R. hominis, while the host cells respond by strengthening gut 
barrier function and enhancing Treg population expansion, possibly via TLR5-flagellin 
signaling. Our data reveal the immunomodulatory properties of R. hominis that could be 
useful for the control and treatment of gut inflammation.
Keywords: Roseburia, T lymphocytes, immune tolerance, inflammatory bowel disease, flagellin, Tlr5
inTrODUcTiOn
The human gut microbiota consists of more than 500–1,000 different phylotypes the majority of 
which belong to the Bacteroidetes and Firmicutes bacterial phyla (1). Successful symbiotic rela-
tionships arising from bacterial colonization of the human gut yield a wide variety of metabolic, 
structural, protective, and other beneficial functions. The immunological importance of the gut 
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microbiota is also well recognized; it is particularly apparent in 
germ-free (GF) animals that have an impaired immune system, 
which, however, can be functionally reconstituted by the intro-
duction of gut commensal bacteria (2–4).
In sharp contrast to the production of secretory intestinal 
IgA, which is mainly driven by microbial colonization per  se 
(5, 6), the development and differentiation of T  cells require 
colonization by specific commensal bacteria. Some species 
of clostridia, such as segmented filamentous bacteria (SFB), 
appear to be potent inducers of differentiation and maturation of 
intestinal Th1, Th17, and Treg cell lineages (7, 8). Recent studies 
have demonstrated that the clostridia clusters IV and XIVa and 
the Altered Schaedler Flora can induce de novo generation of 
Treg cells, while mono-colonization with Bacteroides fragilis can 
correct the Th1/Th2 imbalance in germ-free mice by promoting 
the expansion of Treg cells (4, 9, 10). The effects of commensal 
bacteria on T cell differentiation pathways are variable and may 
be influenced by a specific array of toll-like receptors (TLR) 
ligands associated with particular bacteria (11). For instance, the 
Treg-enhancing effects of B. fragilis are implemented via TLR2 
signaling by polysaccharide A (12).
Dramatic changes in microbiota composition affecting the 
balance of symbionts and pathobionts have been documented in 
gastrointestinal disorders such as inflammatory bowel disease. 
Crohn’s disease (CD), for example, is characterized by a greater 
relative abundance of the Proteobacteria and a reduction of other 
bacteria such as the Bacteroidales and Clostridiales (13–17). 
A specific decrease of Roseburia spp. in patients with CD has also 
been noted (16, 18). Interestingly, this microbial dysbiosis is also 
associated with imbalances in T effector cell populations. The gut 
microbiota alterations in ulcerative colitis (UC) have not been 
characterized to the same extent. Only recently, a study of UC 
patients has demonstrated that Roseburia hominis, together with 
Faecalibacterium prausnitzii, is significantly decreased in this dis-
ease (16, 19). Both species display an inverse correlation with disease 
activity. Previous studies have shown anti-inflammatory effects of 
F. prausnitzii colonization on the host (20). Much less is known 
about R. hominis, which is a member of the clostridia cluster XIVa.
The complete DNA sequence and annotation of the R. hominis 
genome has been previously described (21). In this paper, bacte-
rial and host transcriptome responses to R. hominis colonization 
were investigated. Bacterial responses included expression of 
genes involved in colonization of and adaptation to the environ-
ment of the murine gut, while host responses to colonization 
included genes of immunity and gut function.
MaTerials anD MeThODs
Bacterial cultures
Roseburia hominis A2-183T (=DSM 16839T = NCIMB 14029T) 
and other Roseburia species were maintained and grown on 
synthetic YCFA media as described before (22). Escherichia 
coli and Salmonella enterica strains were cultivated in LB 
medium. All Roseburia culture manipulations were performed 
in a MACS-MG-1000 anaerobic workstation (Don Whitley 
Scientific) under an atmosphere of 80% N2, 10% CO2 and 10% 
H2 at 37°C.
animals, experimental Design,  
and sampling
Germ-free animal experiments were performed in the gnoto-
biotic rodent breeding facility of INRA (ANAXEM platform, 
Institut Micalis, INRA, Jouy-en-Josas, France). The GF C3H/
HeN male mice were allocated into the control (N =  8) and 
treatment (N = 10) groups and caged individually. R. hominis 
A2-183T (=DSM 16839T = NCIMB 14029T) was grown anaero-
bically at 37°C in YCFA media. At days 0, 1, and 2, animals 
in the treatment group were given 109 colony-forming units 
(CFU) of R. hominis culture by gavage, while control animals 
were given 100  µL of YCFA medium. The ileal, ascending 
colonic, and cecal samples were collected at days 14 and 28. GF 
TLR5KO (C57BL/6 genetic background, N = 3) and C57BL/6 
(N =  3) animals (Jouy-en-Josas), and conventional TLR5KO 
(C57BL/6 genetic background, N = 6) and Boy/J (C57BL/6 con-
genic, N = 6) animals (Medical Research Facility, University of 
Aberdeen) were gavaged with the live cultures of R. hominis to 
evaluate its functional importance. Boy/J (C57BL/6 B6 Cd45.1) 
mice were the background controls for conventional TLR5K0. 
They carry a CD45.1 pan leukocyte marker but are otherwise 
equivalent to C57BL/6 wild-type mice (23, 24). Twelve female 
C57BL/6 (6 weeks old) mice were used to evaluate the effect 
of R. hominis during DSS-induced mild colitis. Three mice 
were dosed daily by direct administration of a culture of 
R. hominis for a total of 8 days. Six mice were dosed with culture 
medium. Exposure to DSS was for 4 days (from day 3 to day 6). 
Three R. hominis-dosed and three control mice were offered 
sterile water containing DSS (20  g/L) over this period. 
On day 7, these mice were switched back to sterile water with 
no DSS. The mice were euthanased and dissected aseptically 
on day 9. Twenty-two female C57BL/6 mice (6  weeks old) 
were used to evaluate the effect of R. hominis during DSS-
induced pathological colitis. After the acclimatization period 
of 7–10 days, the mice were dosed daily with 50 µL (109 CFU) 
of R. hominis in growth culture medium for 14 days. Control 
animals were given growth culture medium. From day 9, mice 
were given DSS (MW 50 kDa, 30 g/L) in their drinking water 
for 6 days. The animals were euthanized on day 15 and tissue 
sampling was performed as described earlier. The management 
and experimental procedures with animals were approved by 
the respective Local Ethical Review Committees.
Transcriptome analyses
Bacterial RNA from the mouse cecum contents was isolated 
and labeled with dCTP-Cy3 or dCTP-Cy5 during cDNA synthe-
sis. PCR products amplified from an R. hominis small fragment 
library (6,000 clones) were used to create duplicate microarrays 
on glass slides using a MicroGrid II TAS array-spotting robot 
(BioRobotics). Microarray hybridization was performed in a 
GeneTAC hybridization station (Genomic Solutions). Dye-swap 
and separate RNA purification protocols were used to avoid 
potential biases.
Murine RNA was extracted from the ileum and ascending 
colon tissues and hybridized to the GeneChip “NuGO Mouse 
Array” and GeneChip “Mouse Genome Array” (Affymetrix). 
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Data analysis was performed using R1 and Bioconductor.2 The 
microarray data were submitted to NCBI GEO (Gene Expression 
Omnibus) with accession number GSE25544.
The R. hominis-specific primers 5′-CCCACTGACAGAGTA 
TGTAATGTAC-3′ and 5′-GCACCACCTGTCACCAC-3′ were 
used for qPCR analyses of fecal samples to validate the efficiency 
of colonization. The analyses were performed using a 7500 Fast 
Real-Time PCR System (Applied Biosystems) with a Power SYBR 
Green PCR Master Mix (Applied Biosystems). RT-qPCR analyses 
were performed on the ileal and colonic RNA samples for host 
gene expression studies using a QuantiFast SYBR Green PCR Kit 
(Qiagen) and QuantiTect Primer Assays (Qiagen).
immunofluorescence and histology
FISH analyses were performed with neutral buffered, formalin-
fixed gut tissue sections (2  µm thick) with 16S rRNA probes, 
specific for the domain of Bacteria (Cy3-labeled Eub338) 
and specific for the R. hominis strain A2-183 (FITC-labeled 
GTACATTACATACTCTGTCAGTG). Bacteria were visualized 
at x630 magnification. Immunolocalization of R. hominis flagellin 
was examined in methanol-fixed colon content smears using rab-
bit antisera anti-FlaA1 or anti-FlaA2 (Covalab) and Alexa donkey 
anti-rabbit 488 (Molecular Probes). T cell markers were examined 
on sequential intestinal tissue sections (8 µm) using Ly6G-FITC, 
CD3-FITC, isospecific IgG (BD Biosciences), and double-labeled 
FoxP3 Alexa Fluor 594 (Abcam) and CD3-FITC. Intestinal tissue 
sections (4 µm) were also stained with hematoxylin/eosin. A com-
plete transverse cross-section of the colon from each animal was 
visualized at ×200 magnification. Each field of view was scored 
from 0 to 4 according to the method based on Ref. (25).
cell experiments
Caco-2 and HT29 cells were grown at 37°C in a 75% humidified 
atmosphere with 5% CO2 in 24-well plates. Before any treatment, 
cells were washed twice with Hanks’ Balanced Salt Solution 
and kept in DMEM supplemented with l-glutamine, selenium, 
and transferrin for 24  h. Epithelial cells were harvested after 
incubation for 2 or 4 h and then stored in RNAlater for further 
analyses.
Bone marrow cells were harvested from the femur and tibia of 
C3H/HeN and C57BL/6 mice. Bone marrow-derived dendritic 
cells (BMDCs) were generated by Flt3L or GM-CSF culture, 
stimulated with 100 ng/mL flagellin, and analyzed by flow cytom-
etry. Supernatants were collected and tested for IL-10 and IL-12 
by cytometry bead arrays (BD Bioscience).
Cells from the intestine and mesenteric lymph nodes 
(MLNs) were isolated as described previously (26), with minor 
modifications. In brief, cell suspensions were incubated with 
100  U/mL of collagenase VIII (Sigma-Aldrich) in RPMI 
supplemented with 20% of FBS at 37oC for 20 min (MLN) or 
60  min (intestine). Single cell suspensions were analyzed by 
flow cytometry. For mixed leukocyte reactions, naïve CD4+ 
T cells were purified from the major lymph nodes and spleens 
1 http://www.r-project.org.
2 http://www.bioconductor.org.
of OTII transgenic mice using MACs Miltenyi CD4+ T  cell 
Isolation Kit as per manufactures instruction. Purified CD4+ 
T cells were co-incubated with flagellin activated Flt3L-derived 
BMDCs in the absence or presence of OVA323–339 peptide 
(1 µg/ml). After 5 days, T cell differ entiation was determined 
by flow cytometry.
Flow cytometry
Intestinal lamina propria cells and MLN cells were labeled with 
CD4-FITC, CD25-APC (eBioscience), CD8-APC-Cy7, CD3-
PerCP (Biolegend), and B220-BV570 (BD Biosciences). Labeling 
of intracellular FoxP3 was performed after extracellular staining 
and fixation/permeabilization of cells. GM-CSF-derived dendritic 
cells were labeled with CD11b-PerCP Cy5.5 (BD Biosciences), 
CD11c-PE-Cy7, I-A/I-E-APC-Cy7, CD80-PE, CD86-APC, CD8-
FITC, and B220-BV570 (Biolegend). Flt3L-derived dendritic cells 
were labeled with CD11c-PE-Cy7, CD11b- or Siglec-H-PerCP 
Cy5.5 (Biolegend), I-A/I-E-APC-Cy7, CD317-PE, CD40-Alexa 
Fluor 647, CD103-FITC, and B220-BV570. Coculture T  cells 
were labeled with CD4-PerCP Cy5.5 (BD Biosciences), CD127-
PE-Cy7, CD73-APC, CD195 (CCR5)-FITC, CD62L-BV570, and 
CD25-APC-Cy7 (Biolegend).
statistical analyses
Spot intensities on the microarrays were log-transformed and 
Loess normalization was applied to the microarray results. 
RT-qPCR data were transformed on a base-2 logarithmic scale 
and analyzed by one-way analysis of variance with a significance 
threshold of P < 0.05. Statistical significance between the treat-
ment groups was evaluated using Student’s t-test.
More detailed protocols are available in SI Materials and 
Methods in Supplementary Material.
resUlTs
R. hominis responds to the gut 
environment by Upregulating chemotaxis, 
Motility, and Mobilization genes
Genome analysis (Figure  1A) identified about 5% of all genes 
were related to chemotaxis and motility function including four 
different flagellin genes of which one located within the flagellar 
operon is associated with flagellar motility.
A biomass of R. hominis was given by gavage to GF C3H/HeN 
mice on three consecutive days. R. hominis-colonized both the 
ileum and colon but was found in much higher numbers in the 
colon, up to 1 × 1010 bacteria/g feces (Figure S1 in Supplementary 
Material) and was found to be closely associated with the colonic 
mucosa.
Differential gene expression in the bacterium in response to 
association with the host was investigated using the R. hominis 
microarray. Bacterial RNA was isolated from three different 
experimental conditions to distinguish between the effects of the 
gut environment and animal dietary components, (i) in vivo, from 
the cecum of mono-associated mice; (ii) in vitro, from bacteria 
grown in the presence of dietary components; and (iii) in vitro, 
from bacteria grown in culture.
FigUre 1 | Sequence features of Roseburia hominis genome and differentially expressed transcripts in the murine gut after mono-association with R. hominis.  
(a) Subsystem category distribution in the genome of R. hominis according to RAST. The largest subsystem feature counts belong to carbohydrates, amino acids 
and derivatives, and protein metabolism. (B) The number of differentially expressed genes in R. hominis-colonized mice (N = 5) compared to germ-free (GF) control 
(N = 4) identified with the Affymetrix microarray. Bar graphs represent the number of genes up- or downregulated in mice after 14 and 28 days of colonization. 
(c) Heatmap generated from differentially expressed genes with functional significance between GF and R. hominis-colonized mice at 14 and 28 days.
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Colonization of GF mice with R. hominis correlated with the 
increased host gene expression, which was highest in the colon, 
particularly at day 28 post-colonization (Figure 1B). The number 
of differentially expressed genes in the ileum was very low at day 
28, consistent with the reduced bacterial numbers. Differential 
transcriptome responses in the two tissue sites and time points 
were illustrated by a clear separation of significant transcripts in 
the heatmap analysis (Figure 1C).
Differentially expressed genes were identified (in  vivo vs. 
in vitro) with RT-qPCR validation performed on 42 differentially 
expressed genes (Tables S1 and S2 in Supplementary Material). 
The mobA- and mobL-like genes that are involved in conjugation/ 
mobilization transfer showed strong upregulation in  vivo 
(Figure  2A). Other subsystems induced by the gut environ-
ment included membrane transport, in particular magnesium 
transport, and motility and chemotaxis including multiple 
methyl-accepting chemotaxis proteins and genes of the flagellar 
operon (Figure 2B). R. hominis possesses multiple flagellin genes: 
flaA1, flaA2, flaA3, and flaB. The expression of flaA1and flaA2 
in the murine gut environment was verified by Western–blot and 
immunocytochemistry (Figure 2C).
R. hominis affects host innate signaling 
Pathways
Genes involved in innate immunity and gut barrier function of 
the host were significantly induced by R. hominis colonization 
[Figure 1C; NCBI GEO (Gene Expression Omnibus), accession 
number GSE25544]. The GO process “innate immune response” 
(GO:0045087) was upregulated and included the TLR-related 
genes Tlr5, Tlr1, and Vnn1. The upregulation of Tlr5 was of par-
ticular interest, given the presence of flagellar genes in the genome 
of R. hominis and the expression of the corresponding proteins in 
the gut of mono-colonized mice. The flagellins may have a role 
in this innate signaling pathway to mediate innate and adaptive 
immune responses. Other innate immunity genes affected by R. 
hominis colonization included the antimicrobial peptides Defb37, 
Pla2g3, Muc16, and Itln and the gut barrier function genes Sprr1a, 
Cldn4, Pmp22, Crb3, and Magi3. Innate immunity genes that 
were upregulated in the ileum in response to R. hominis included 
Defcr20, Pcgf2, Ltbp4, Igsf8, and Tcfe2a. We also found a negative 
regulation of the NF-κB pathway (GO:0043124) by R. hominis, 
which may contribute to the immune homeostasis by downregu-
lating this inflammatory cascade.
FigUre 2 | Responses of Roseburia hominis to the gut environment. (a) RT-qPCR quantification of R. hominis transcripts involved in conjugation/mobilization 
transfer. R. hominis RNA samples: in vivo—isolated from mono-associated animals; in vitro—isolated from YCFA medium-grown cultures; in vitro + diet—isolated 
from cultures grown on YCFA medium with addition of murine chow. (B) RT-qPCR quantification of R. hominis transcripts involved in motility and chemotaxis.  
R. hominis RNA samples: in vivo—isolated from mono-associated animals; in vitro—isolated from YCFA medium-grown cultures; in vitro + diet—isolated from 
cultures grown on YCFA medium with addition of murine chow. (c) Western blot of R. hominis proteins grown in vitro in the presence of UV-irradiated standard 
murine chow. The membrane was immunostained with affinity-purified 1 antibody, Fla2 specific antiserum, and anti-DNA gyrase A antibody (lane 1: no diet, lane 2: 
0.01 g diet/10 mL of R. hominis culture, lane 3: 0.02 g diet/10 mL, lane 4: 0.05 g diet/10 mL, lane 5: 0.1 g diet/10 mL, lane 6: 0.2 g diet/10 mL, lane 7: 0.5 g 
diet/10 mL, and lane 8: 1 g diet/10 mL). Electron microscopy of R. hominis showing flagella (black arrows). (D) Immunocytochemistry with FlaA1 and FlaA2 specific 
antisera performed on R. hominis from the luminal contents of mono-colonized mice and on R. hominis grown in vitro. Original magnification is ×1,000. RT-qPCR 
results are presented as fold change. Statistical significance: *P < 0.05, **P < 0.01, and ***P < 0.001.
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R. hominis Directs T cell Pathways
Immune response was a major pathway induced by R. hominis at 
day 28 in the ascending colon of mono-associated mice. The path-
ways significantly affected in this category were mostly involved 
in T  cell function, including IL-10 signaling and regulation of 
T cell function by CTLA-4 (Table S3 in Supplementary Material). 
The Ly6 gene family was also induced in the ascending colon. 
In particular, the GPI-anchored gene product of Ly6g6c was 
upregulated 25-fold, and the related gene Ly6g6e was upregulated 
twofold at day 28. The majority of hematopoietic cells, including 
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neutrophils and plasmacytoid dendritic cells, express one or more 
members of the Ly6 family. The increased presence of Ly6G+ cells 
in R. hominis-colonized mice was confirmed by immunocyto-
chemistry (Figure 3A).
While the pathways of T  cell regulation were significantly 
influenced by association with R. hominis, the corresponding 
effects on T  cell differentiation required further investiga-
tion. We therefore assessed the number of double-positive 
CD3+FoxP3+ cells in the colonic lamina propria of mono-
associated C3H/HeN mice. A significant increase in the num-
ber of regulatory T  cells (CD3+FoxP3+ cells) was detected in 
the germfree C3H/HeN and C56BL/6 mice colonized with R. 
hominis (Figures 3A,B).
Conventional C3H/HeN and C57BL/6 mice were gavaged with 
R. hominis for 14 days to determine the impact of the bacterium on 
Treg cells in the lamina propria of animals with a normal micro-
biota. This treatment resulted in a small but significant increase 
in the population of CD3+CD4+CD25+FoxP3+ T  cells in the 
C3H/HeN (P = 0.04) and a smaller increase in the C57BL/6 mice 
(P = 0.05) when compared to non-colonized mice (Figure 3C). 
While the population of Tregs was induced in conventional mice 
after colonization with R. hominis under homeostatic conditions, 
it was unknown if this induction could be maintained under 
conditions of mild colitis. We therefore investigated the impact 
of the bacterium on Treg cells in the lamina propria of animals 
that were given low dose DSS. FoxP3-tagged mice of C57BL/6 
background were colonized with R. hominis for 2  days before 
treatment with low dose of DSS for 4 days followed by 2 days of 
pure drinking water. DSS treatment alone significantly increased 
the population of CD3+CD4+CD25+FoxP3+ T  cells (P =  0.02) 
(Figure 3D). When the animals were additionally treated with 
R. hominis, there was a further significant increase in the popula-
tion of CD3+CD4+CD25+FoxP3+ T cells (P = 0.02) versus DSS 
(Figures 3D,E).
The role of R. hominis Flagellins in 
Modulation of T cell Differentiation
The influence of bacteria on the differentiation of T  cells may 
reflect a specific array of TLR ligands displayed by a particular 
bacterium. TLR5KO (GF and conventional) and WT murine 
strains were gavaged with the bacterium to evaluate the func-
tional importance of R. hominis and its flagellins. Analysis of the 
differentially expressed genes in TLR5KO and WT Boy/J mice 
colonized with R. hominis revealed that although T cell pathways 
were still influenced by the colonization event in TLR5KO mice, 
responses were more related to IL-4, IL-5, IL-6, IL-9 pathways and 
not to IL-10 and CTLA-4 (Table S4 in Supplementary Material). 
Furthermore, in contrast to mono-associated C3H/HeN and 
C57BL/6 animals (Figure  3B) and conventional Boy/J animals 
(Figures  4B,C), the numbers of double-positive CD3+FoxP3+ 
cells in the lamina propria of TLR5KO mice were not increased 
due to R. hominis treatment (Figure 4A).
A set of flagellins from pathogenic and commensal bacteria, 
including recombinant R. hominis flagellins, was used to com-
pare their effect on activation of signaling responses in IECs and 
BMDCs. Caco-2 cells were treated with the identical concentra-
tions of different bacterial flagellins (Figure  5A). The flagellin 
of pathogenic S. enterica serotype Enteritidis (SE) induced a 
larger gene panel than the flagellins of commensal E. coli K12 or 
R. hominis FlaA1. E. coli and R. hominis induced a strong response 
and, with a similar gene complement between the two, formed 
a separate clade distinct from SE. In contrast, FlaA2 was gener-
ally neither pro-inflammatory nor did it activate the conserved 
gene signature (IL8, CXCL1, CXCL2, and CXCL10) that was 
induced by the other recombinant bacterial flagellins. In fact, the 
set of genes affected was closer to that of the control cells and 
formed a cluster separated from the other flagellins. FlaA1 from 
R. hominis induced different responses in Flt3L- and GM-CSF-
derived BMDCs compared to SE and K12 (Figures  5B,C). 
In particular, FlaA1 was uniquely able to activate Flt3L-expanded 
DCs, with the upregulation of I-A/I-E and CD40 and production 
of IL-10 by BMDCs from both C3H/HeN and C57BL/6 mice. 
The IL-10/IL-12 ratio was particularly elevated in C57BL/6 DCs 
(Figure 5D), which were found to be CD103+Siglec-H+. To test 
whether flagellin activated BMDCs could differentially modulate 
naïve T  cell differentiation, mixed leukocyte cultures of CD4+ 
OTII cells with flagellin stimulated Flt3-derived BMDC were 
performed. The data show that the production of IL-10 and IL-12 
by the flagellin stimulated Flt3-derived BMDC ratio triggered 
naïve T  cell differentiation toward a Tregs profile (Figure  5E). 
In contrast to FlaA2, FlaA1 significantly increased the Treg 
population in the T cell cocultures.
R. hominis attenuates colitis  
in Dss-Treated Mice
The effects of R. hominis on innate and adaptive immunity 
prompted us to test its therapeutic efficacy using the murine 
DSS model (Figure S2 in Supplementary Material; Figure 6). The 
treatment group was dosed daily with R. hominis (~50 μL, ca. 
109 CFU) via gavage for a period of 14 days while the untreated 
group received the same amount of bacterial growth medium. 
The two groups were then given DSS in drinking water (MW 
50  kDa, 30  g/L) beginning from day 8 onward. On day 15, 
DSS-treated mice without R. hominis addition had a strong 
elevation of a panel of pro-inflammatory biomarkers compared 
to control mice, with gene induction levels ranging from 4- to 
49-fold (Figure 6A). Induction of pro-inflammatory genes was 
significantly lower in the R. hominis-treated mice compared to 
the control group, indicating a strong therapeutic benefit of oral 
administration of R. hominis. On day 15, severe inflammation 
was detected in the ascending colon of DSS-treated mice without 
an R. hominis supplement, while the colonic mucosa in the R. 
hominis-supplemented group displayed only low-level inflamma-
tion, consistent with the reduced expression of pro-inflammatory 
genes (Figures 6B,C). Treatment with R. hominis also alleviated 
the weight loss in DSS-treated mice (Figure S3 and Table S5 in 
Supplementary Material).
R. hominis colonization influences  
Body composition and expression  
of satiety genes
In the next set of experiments, we investigated metabolic changes 
in the host and bacterium due to host–microbe association. 
Mice mono-associated with R. hominis displayed significant 
FigUre 3 | Induction of FoxP3+ Treg cells by Roseburia hominis. (a) Immunofluorescence analysis of lamina propria cells labeled with (i) anti-Ly6G, (ii) anti-CD3, 
and (iii) anti-CD3/anti-FoxP3 in the ascending colon of germ-free (GF) and R. hominis-treated C3H/HeN mice. Data are shown as the number of positive cells per 
field of view in GF (N = 7–8) and R. hominis-treated mice (N = 8–10). Original magnification ×630. Statistical significance: *P < 0.05. (B) Immunofluorescence 
analysis of lamina propria cells in the ascending colon labeled with anti-CD3 and anti-FoxP3 in germ-free and R. hominis mono-colonized C3H/HeN (N = 8) and 
C57BL/6 (N = 3) mice. (c) Flow cytometry analysis of FoxP3+ Treg cells in the lamina propria of conventional mice treated for 14 days with R. hominis: C3H/HeN 
mice (*P = 0.04 between control and R. hominis treatment) and C57Bl/6 mice (**P = 0.05 between control and R. hominis treatment). (D) Flow cytometry analysis of 
FoxP3+ Tregs in lamina propria of FoxP3-tagged conventional mice treated for 8 days with R. hominis, with 4 days of low dose DSS treatment or untreated. 
Statistical significance: *P < 0.005 control versus DSS treatment and **P = 0.02 DSS treatment versus DSS+ R. hominis treatment. (e) Flow cytometry plots of 
FoxP3+ Treg cells in the colonic lamina propria of DSS-treated mice and DSS+ R. hominis-treated mice. Plots are representative of three experiments. The gating 
strategy for the FACS plots was as follows: FSC/SSC (removal of cell debris), live/dead-SSC, singlets (FSC-A/FSC-H), CD3+CD8−, and CD25+FoxP3+. The 
percentages were calculated as CD25+FoxP3+ cells of total CD4+ T cells in each preparation. CD4+ cells were derived from the gating strategy of CD3+CD8−.
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metabolic changes compared to control GF mice. In particular, 
the GO processes “negative regulation of response to food” 
(GO:0032096), “negative regulation of appetite” (GO:0032099), 
and “regulation of catecholamine secretion” (GO:0050433) were 
all downregulated in the ascending colon after colonization by 
R. hominis [NCBI GEO (Gene Expression Omnibus), accession 
FigUre 4 | Modulation of T cell differentiation by Roseburia hominis flagellins. (a) Quantification of lamina propria cells in the ascending colon immunofluorescently 
labeled with anti-CD3 and anti-FoxP3 in germ-free (GF) and R. hominis mono-colonized TLR5KO mice (N = 2). (B) Flow cytometry plots of FoxP3+ Treg cells in the 
colonic and small intestinal lamina propria and mesenteric lymph nodes (MLNs) of conventional TLR5KO mice and Boy/J WT mice treated for 14 days with  
R. hominis. (c) Flow cytometry analysis of FoxP3+ Treg cells in conventional TLR5KO mice and Boy/J WT mice treated for 14 days with R. hominis: in the colonic 
lamina propria (P = 0.01 between TLR5KO and WT), in the lamina propria of the small intestine (P = 0.03 between TLR5KO and WT), and in MLNs (P = 0.33 
between TLR5KO and WT).
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number GSE25544]. The genes involved in these processes were 
Agt, Cartpt, Cck, and Cxcl12, with the corresponding mRNA 
changes induced ranging from 2- to 12-fold. Cck, in particular, 
plays a major role in digestion and satiety as a hunger suppressant. 
Gcg expression was also downregulated at this gut site.
To establish whether the transcriptional changes of these 
genes have any physiological relevance in terms of body composi-
tion, analyses of dry carcass weight and lipid composition were 
performed. Dry carcass weights of R. hominis-associated mice 
were significantly heavier than those of GF animals (Figure 7A). 
Carcass lipid analysis showed that the total adiposity was also 
significantly higher in R. hominis-colonized animals at day 14 
(Figure 7B).
Significant metabolic changes were also detected on the other 
side of the host–microbe interaction spectrum. In particular, 
expression of R. hominis genes involved in butyrate produc-
tion was upregulated by the gut environment (Figure  7C). 
These were the genes encoding acetyl-CoA acetyltransferase, 
3-hydroxyacyl-CoA dehydrogenase, butyryl-CoA dehydroge-
nase, and phosphoenolpyruvate carboxykinase. The stimula-
tory effect of host epithelial cells on production of acetate and 
butyrate by R. hominis was further confirmed in separate 
in  vitro experiments (Figure S4 in Supplementary Material). 
Bacterial cells incubated with Caco-2 and HT29 cells produced 
significantly higher amounts of these metabolites compared to 
R. hominis control cells incubated under the same conditions 
but without the epithelial cells.
DiscUssiOn
A long-term co-evolution of host–microbe interaction has likely 
driven the selection of functionally important bacterial species 
in the gut, the majority of which are not encountered in other 
ecosystems. There is only limited information available at present 
about the contribution of individual members of the microbial 
community to intestinal functions, in particular to the develop-
ment and regulation of mucosal immunity.
The specific functions of certain intestinal bacteria such as 
B. fragilis and SFB have been investigated in the mouse gut to 
define their individual contributions to T cell biology, and these 
bacteria have been shown to be potent inducers of Tregs and 
Th17 cells (4, 7, 8). Members of the Clostridium clusters IV and 
XIVa have recently received more attention. For instance, their 
presence in the altered Schaedler flora and the contribution of a 
FigUre 5 | Effects of Roseburia hominis flagellin FlaA1 on intestinal epithelial cells and murine bone marrow-derived dendritic cells. (a) Heatmap of differentially 
expressed genes in Caco-2 cells treated with different bacterial flagellins: from Salmonella enterica serotype Enteritidis (SE), Escherichia coli K12 (K12), and  
R. hominis (FlaA1 and FlaA2). (B) Expression of CD40; I-A/I-E and CD103 by CD11c+B220+CD317+ Flt3L-derived dendritic cells from conventional C3H/HeN, 
control (blue) and after 24 h incubation with recombinant flagellins (SE, K12, FlaA1, FlaA2; all in green) determined by flow cytometry. Histogram represents data 
from three experiments. (c) Frequencies of Flt3L- and GM-CSF-derived dendritic cells from conventional C3H/HeN gated on CD11c+B220+CD317+ cells and 
CD11c+CD11b+B220− cells treated with different recombinant flagellins (SE, K12, FlaA1, and FlaA2). Results are shown as the percentage of the total, live and 
singlet cells, mean ± SD from three experiments. (D) The level of IL-10 and IL-12 cytokines was measured by cytometry bead arrays in supernatants from control 
(unstimulated DCs; N = 3) and FlaA1-treated DCs (N = 3) derived from C3H/HeN and C57BL/6. Data are presented as mean ± SD. Statistical significance: 
***P < 0.001. (e) Flagellin stimulated Flt3-derived dendritic cells were cocultured with CD4+ T cells for 5 days, and T cell were stained for the expression of T cell 
differentiation markers. Graph indicates the percentage of activated Treg cells. Statistical significance: **P < 0.01.
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mixed culture of Clostridium spp. to T cell differentiation has also 
been noted (9, 10).
We report here the successful and stable mono-association of 
R. hominis, a strictly anaerobic flagellated member of the 
Firmicutes phylum, in the gut of GF mice. The transcriptional 
responses of R. hominis following mono-colonization could 
be attributed to both the host gut environment and diet. 
These included chemotaxis and motility subsystems. The role 
of motility and the flagellar apparatus in host colonization 
is well understood for pathogenic bacteria but less is known 
FigUre 6 | Roseburia hominis attenuates inflammation in the DSS model of colitis. (a) DSS mice untreated with R. hominis (N = 8) had strong elevation of all genes 
compared to the control mice (N = 4), while differential gene expression was lower in R. hominis-treated animals (N = 10). RT-qPCR results obtained on day 15 are 
presented as a fold change compared to control. Statistical significance: ***P < 0.001. (B) Histopathology tissue scoring (25) presented as mean percentage of 
fields of view at a given grade. DSS treatment significantly altered all fields of view at grades 0, 2, 3, and 4. R. hominis significantly reduced the % fields of view for 
grade 4 pathology (P = 0.02) and increased the % fields of view for grade 0. Data obtained on day 15 are presented as mean ± SD. (c) Ascending colon 
(hematoxylin/eosin stained) of control, DSS+ R. hominis-treated and DSS-treated animals. Images shown are the representative fields of view for each treatment 
group with the allocated score in parenthesis. Single black arrow head indicates infiltrating cells, and the double headed arrow indicates transmural infiltration.  
L, lumen. Original magnification ×200. Scale bar represents 50 µm.
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about the role of flagellins in commensal bacteria. Genes 
encoding cell motility functions, and flagellins in particular, 
are generally expressed at variable and low abundance rates in 
the gut microbiome (27). In addition, only a subset of human 
gut microbiomes contains detectable flagellin genes (28). 
We showed that R. hominis flagellins are expressed in the mouse 
intestinal environment. Flagellin gene expression appears to be 
partly dependent on the presence of certain dietary constitu-
ents. Previous work has shown that flagellin gene expression of 
the related species Roseburia inulinivorans is indeed substrate 
dependent; its expression is higher in the presence of starch 
compared to glucose, inulin, or fructan (29).
The presence of R. hominis in the gut induces genes involved 
in promoting gut barrier function and innate immunity. Tight 
junctions, gap junctions, and adherens junctions operate to 
limit bacterial translocation to the subepithelial layer of the 
gut, and these functions may be promoted by intestinal bacteria 
(30). Both CD and UC are characterized by the loss of barrier 
function and the integrity of tight junctions. Interestingly, 
dysbiosis of the gut microbiota in UC and CD is associated 
with a significant reduction of R. hominis and F. prausnitzii 
(16, 19). Our results concerning the active contribution of 
R. hominis to gut barrier function support the view that its loss 
in patients with CD or UC may have significant consequences. 
Tight junction complexes can be activated by a number of other 
commensal and probiotic bacteria (31), potentially contribut-
ing to the amelioration of the “leaky gut” condition in these 
diseases.
Roseburia hominis induced the expression of genes such as 
Ly6g6c, as well as pathways involved in the regulation of T cells. 
The most affected T cell pathways included those related to IL-10, 
ICOS, and CTLA-4, which are all involved in the differentiation 
FigUre 7 | Roseburia hominis colonization influences satiety genes and body weight. The germ-free (GF) C3H/HeN male mice were allocated into the control 
(N = 8) and treatment (N = 10) groups. At days 0, 1, and 2, animals in the treatment group were dosed by ~109 CFU of R. hominis in YCFA medium (100 µL) by 
gavage, while control animals were given 100 µL of YCFA medium alone. Dry body weight and lipid content of carcasses were analyzed. (a) Weight of dry carcasses 
of R. hominis-associated mice was significantly heavier compared to GF animals. (B) Carcass lipid analyses showed that the total adiposity was also significantly 
higher in R. hominis-associated animals at day 14. Data are presented as mean ± SD. (c) RT-qPCR analysis of genes involved in butyrate metabolism.
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of Treg cells. Significant increases in colonic CD3+CD4+CD2
5+FoxP3+ cells were observed in mice either mono-colonized 
with R. hominis or in conventional mice fed a supplement of live 
R. hominis culture. Our findings complement recent reports on 
Treg differentiation effects by other Clostridium species (10, 32). 
We have shown here that the single bacterial strain R. hominis 
A2-183 is able to promote mucosal T cell expansion and impact 
T  cell differentiation in mono-associated, conventional and 
DSS-treated mice.
Members of the Roseburia genus are some of the most 
prevalent motile bacterial species in the normal healthy 
human intestinal microbiota (33). Flagellins are potent immu-
nomodulatory proteins: flagellated bacteria, such as R. hominis, 
could interact actively with the host immune system. Another 
important consequence of motility among the Roseburia spe-
cies is their ability to penetrate the mucus layer and attach 
to the host gut epithelial cell surfaces (34). This property is 
considered to be a very desirable characteristic enhancing the 
probiotic potential of bacteria (35). Close proximity to the 
host cells allows commen sal gut bacteria to exert potent physi-
ological effects, potentially reversing metabolic disorders and 
controlling inflammation, gut barrier function, and gut peptide 
secretion.
Flagellin signaling by many pathogenic bacteria through 
the host’s TLR5 receptors induces a strong pro-inflammatory 
response, mainly driven by the activation of the NF-κB signal-
ing pathway (36). However, the numerical prevalence of flagel-
lated commensal bacteria makes a strong pro-inflammatory 
scenario seem unlikely. These bacteria are capable of flagellin/
TLR5 signaling, which is important for host defense and 
disease protection, because deletion of TLR5 results in coli-
tis (37). The presence of flagellin genes in the SFB genomes 
(38, 39) may explain the potent induction of Th17 cells by these 
bacteria (7, 8).
Differential expression of R. hominis flagellins in vitro has 
effects on IECs and BMDCs. The panel of flagellins tested 
affected IECs and BMDCs differently, although all the flagellin 
structures included the conserved Arg90 domain associated 
with flagellins that bind and activate TLR5 (40), which sug-
gests that other sequence/structural properties might account 
for the signaling responses mediated by FlaA1 and FlaA2. 
Certain commensal flagellin structures may help to direct 
immune tolerance responses through TLR5 expressed on 
either CD103+DC or Treg subsets (23, 41, 42). The significance 
of flagellin-TLR5 signaling in Treg responses induced by 
R. hominis was further investigated using TLR5KO mice. We 
showed that R. hominis-induced CD3+CD4+CD25+FoxP3+ 
cells were significantly lower in TLR5KO mice, indicating 
that TLR5/flagellin signaling is an important mediator for the 
expansion of this T cell subset. The immunomodulatory effects 
of R. hominis were shown in DSS-treated mice. Although the 
DSS model of colitis is generally a T cell-independent model, we 
showed that R. hominis induced regulatory T cell populations 
in these animals. Other anti-inflammatory molecules such as 
butyrate may also contribute to immune tolerance and limit 
tissue damage (43, 44). Another effect of short-chain fatty acids 
produced by the bacterium is the improved food conversion 
efficiency. The dietary constituents such as polysaccharides that 
are poorly utilized by the host are degraded by the bacterium 
and used by the host resulting in a better energy recovery from 
the diet. Differential expression of satiety genes may be another 
factor contributing to the heavier weight and higher adiposity 
in R. hominis-colonized animals.
In summary, gut colonization with R. hominis caused the 
induction of specific subsets of genes on both the bacterial and 
host sides of the interaction. In this study, we have focused on 
signaling amongst other molecular mechanisms to explain the 
nature of this cross talk. TLR5/flagellin signaling could, poten-
tially, drive the expansion of Treg cells via a TLR5-dependent 
mechanism, and our results suggest a potential therapeutic ben-
efit of R. hominis in the treatment of UC, which is characterized 
by the loss of this bacterium from the gut (16).
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